Formalin-fixed paraffin-embedded sections were dewaxed in xylene and rehydrated in graded alcohols prior to antigen retrieval in Tris-EDTA pH9. Slides were blocked and incubated with primary antibodies at 4 °C overnight (
CD31 (JC/70A, Abcam), Ki67 (EPR3610, Abcam), CD8 (SP16, Invitrogen), Granzyme B (NCL-L-GRAN-B, Leica), PD-1 (AF1086, RnD Systems), CD4 (EPR6855, Abcam),
FOXP3 (236A/E7, Abcam), SMA (ab5694, Abcam), CD68 (KP1, Invitrogen)). Samples were washed and incubated in fluorescently conjugated secondary antibodies; nuclei were counterstained with DAPI. Whole slides were scanned at ×40 magnification on the Zeiss
Axio Scan Z1 system. Image analysis was performed using
HALO Software (Indica Labs, analysis algorithms: HighPlex FL v3.1.0, Object Colocalization FL v1.0, Area Quantification FL v2.1.5).
Stewart G.D., Welsh S.J., Ursprung S., Gallagher F.A., Jones J.O., Shields J., Smith C.G., Mitchell T.J., Warren A.Y., Bex A., Boleti E., Carruthers J., Eisen T., Fife K., Hamid A., Laird A., Leung S., Malik J., Mendichovszky I.A., Mumtaz F., Oades G., Priest A.N., Riddick A.C., Venugopal B., Welsh M., Riddle K., Hopcroft L.E, & Jones R.J. (2022). A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA). British Journal of Cancer, 127(6), 1051-1060.